Futurenow,
I read it that the Total potential revenue if the entire market is $100m, whether addressed via Adheris or PDX or any other operator (and clearly not all be one provider either. Not $100m each, clearly Adheris gives better access to more pharmacies so proportionately more of the total addressable market can POTENTIALLY be released. Just my thoughts on how I read the presentation and happy to be corrected.
Regardless this is a step change announcement, but if the PDX agreement can be so easily dismissed, it does show what these agreements are worth until actually executed upon. Hopefully with the board ties ups, we see this licence deal pan out - just my ramblings and GLTAH
Cheers
Charlie
Ann: MedAdvisor Announces Agreement with Adheris Health SA, page-18
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $84.31K | 299.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 209547 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 94066 | 1 |
View Market Depth
| Last trade - 12.52pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
